Screener
West Pharmaceutical Services WST Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income | $154.0 | $131.8 | $292.8 | $221.6 |
| Other comprehensive (loss) income, net of tax: | ||||
| Foreign currency translation adjustments, net of tax of $0.4 and $(1.0), $0.5 and $(2.1), respectively | (14.1) | 114.9 | (33.6) | 165.3 |
| Defined benefit pension and other postretirement plan adjustments, net of tax of $0.0 and $(0.2), $0.0 and $(0.3), respectively | (0.1) | (0.7) | (0.2) | (1.1) |
| Net gain on equity affiliate accumulated other comprehensive income, net of tax of $0.0 and $0.0, $0.0 and $0.0, respectively | (0.1) | 0.1 | (0.1) | 0.2 |
| Net (loss) gain on derivatives, net of tax of $(0.3) and $0.8, $(0.2) and $1.7, respectively | (0.9) | 2.5 | (1.0) | 5.0 |
| Other comprehensive (loss) income, net of tax | (15.2) | 116.8 | (34.9) | 169.4 |
| Comprehensive income | $138.8 | $248.6 | $257.9 | $391.0 |
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is West Pharmaceutical Services's comprehensive income (loss), net of tax, attributable to parent?
- West Pharmaceutical Services (WST) reported comprehensive income (loss), net of tax, attributable to parent of $138.8M in Q2 2026.
- How has West Pharmaceutical Services's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- West Pharmaceutical Services's comprehensive income (loss), net of tax, attributable to parent decreased by 44.2% year-over-year, from $248.6M to $138.8M.
Ask your AI about West Pharmaceutical Services's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude